Oxysterol derivatives of cholesterol in neurodegenerative disorders

Current Medicinal Chemistry

Volumn 18, Issue 10, 2011, Pages 1515-1525

  Jeitner, T M ^a   Voloshyna, I ^a   Reiss, A B ^a  

^a WINTHROP UNIVERSITY HOSPITAL   (United States)

Author keywords

Cholesterol metabolism; Neurodegenerative syndromes; Oxysterols

Indexed keywords

CELL NUCLEUS RECEPTOR; CHOLESTEROL DERIVATIVE; LIGAND; MYELIN; OXYSTEROL;

ALZHEIMER DISEASE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN FUNCTION; CHOLESTEROL METABOLISM; CHOLESTEROL TRANSPORT; DEGENERATIVE DISEASE; GENE EXPRESSION; HUMAN; LIPID METABOLISM; METABOLITE; MULTIPLE SCLEROSIS; NONHUMAN; PROGNOSIS; SPASTIC PARAPLEGIA;

ALZHEIMER DISEASE; ANIMALS; BLOOD-BRAIN BARRIER; CHOLESTEROL; HUMANS; HYDROXYCHOLESTEROLS; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; PARAPLEGIA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 79954986242     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986711795328445     Document Type: Article

References (146)

1. Russell, D.W.; Haiford, R.W.; Ramirez, D.M.; Shah, R.; Kotti, T. Cholesterol 24-hydroxylase: An enzyme of cholesterol turnover in the brain. Annu. Rev Biochem., 2009, 78, 1017-1040.
2. Bjorkhem, I.; Leoni, V.; Meaney, S. Genetic connections between neurological disorders and cholesterol metabolism. J. Lipid Res., 2010, 51, 2489-2503.
3. Bjorkhem, I.; Meaney, S. Brain cholesterol: Long secret life behind a barrier. Arterioscler. Thromb. Vasc. Biol, 2004, 24, 806-815. (Pubitemid 38620856)
4. Bjorkhem, I.; Cedazo-Minguez, A.; Leoni, V.; Meaney, S. Oxysterols and neurodegenerative diseases. Mol. Aspects Med., 2009, 30, 171-179.
5. Xie, C.; Lund, E.G.; Turley, S.D.; Russell, D.W.; Dietschy, J.M. Quantitation of two pathways for cholesterol excretion from the brain in normal mice and mice with neurodegeneration. J. Lipid Res., 2003, 44, 1780-1789. (Pubitemid 37185890)
6. Piomelli, D.; Astarita, G.; Rapaka, R. A neuroscientist's guide to lipidomics. Nat. Rev Neurosci., 2007, 8, 743-754. (Pubitemid 47462119)
7. Dietschy, J.M.; Turley, S.D. Cholesterol metabolism in the brain. Curr. Opin. Lipidol, 2001, 12, 105-112. (Pubitemid 32242918)
8. Bjorkhem, I.; Lutjohann, D.; Breuer, O.; Sakinis, A.; Wennmalm, A. Importance of a novel oxidative mechanism for elimination of brain cholesterol. Turnover of cholesterol and 24(s)-hydroxycholesterol in rat brain as measured with 18o2 techniques in vivo and in vitro. J. Biol. Chem., 1997, 272, 30178-30184. (Pubitemid 27512218)
9. Davison, A.N. Brain sterol metabolism. Adv. Lipid. Res., 1965, 3, 171-196.
10. Russell, D.W. Oxysterol biosynthetic enzymes. Biochim. Biophys. Acta., 2000, 1529, 126-135.
11. Bjorkhem, I. do oxysterols control cholesterol homeostasis? J. Clin. Invest., 2002, 110, 725-730.
12. Burkard, I.; von Eckardstein, A.; Waeber, G.; Vollenweider, P.; Rentsch, K.M. Lipoprotein distribution and biological variation of 24s-and 27-hydroxycholesterol in healthy volunteers. Atherosclerosis, 2007, 194, 71-78. (Pubitemid 47464309)
13. Radhakrishnan, A.; Ikeda, Y.; Kwon, H.J.; Brown, M.S.; Goldstein, J.L. Sterol-regulated transport of srebps from endoplasmic reticulum to golgi: Oxysterols block transport by binding to insig. Proc. Natl. Acad. Sci. U.S.A., 2007, 104, 6511-6518. (Pubitemid 47175533)
14. Gill, S.; Chow, R.; Brown, A.J. Sterol regulators of cholesterol homeostasis and beyond: The oxysterol hypothesis revisited and revised. Prog. Lipid Res., 2008, 47, 391-404.
15. Bellosta, S.; Corsini, A.; Bernini, F.; Granata, A.; Didoni, G.; Mazzotti, M.; Fumagalli, R. 27-hydroxycholesterol modulation of low density lipoprotein metabolism in cultured human hepatic and extrahepatic cells. FEBS Lett., 1993, 332, 115-118. (Pubitemid 23295910)
16. Janowski, B.A.; Willy, P.J.; Devi, T.R.; Falck, J.R.; Mangelsdorf, D.J. An oxysterol signalling pathway mediated by the nuclear receptor lxr alpha. Nature, 1996, 383, 728-731. (Pubitemid 26360651)
17. Szanto, A.; Benko, S.; Szatmari, I.; Balint, B.L.; Furtos, I.; Ruhl, R.; Molnar, S.; Csiba, L.; Garuti, R.; Calandra, S.; Larsson, H.; Diczfalusy, U.; Nagy, L. Transcriptional regulation of human cyp27 integrates retinoid, peroxisome proliferator-activated receptor, and liver x receptor signaling in macrophages. Mol. Cell. Biol., 2004, 24, 8154-8166. (Pubitemid 39167464)
18. Zelcer, N.; Tontonoz, P. Liver x receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest., 2006, 116, 607-614. (Pubitemid 43326865)
19. Costet, P.; Luo, Y.; Wang, N.; Tall, A.R. Sterol-dependent transactivation of the abc1 promoter by the liver x receptor/retinoid x receptor. J. Biol. Chem., 2000, 275, 28240-28245.
20. Ory, D.S. Nuclear receptor signaling in the control of cholesterol homeostasis: Have the orphans found a home? Circ. Res., 2004, 95, 660-670. (Pubitemid 39331925)
21. Sato, R. Sterol metabolism and srebp activation. Arch. Biochem. Biophys., 2010, 501, 177-181.
22. Lund, E.G.; Diczfalusy, U. Quantitation of receptor ligands by mass spectrometry. Methods Enzymol., 2003, 364, 24-37. (Pubitemid 37419916)
23. Jurevics, H.; Morell, P. Cholesterol for synthesis of myelin is made locally, not imported into brain. J. Neurochem., 1995, 64, 895-901.
24. Farooqui, A.A. Lipid mediators in the neural cell nucleus: Their metabolism, signaling, and association with neurological disorders. Neuroscientist, 2009, 15, 392-407.
25. Lutjohann, D.; Breuer, O.; Ahlborg, G.; Nennesmo, I.; Siden, A.; Diczfalusy, U.; Bjorkhem, I. Cholesterol homeostasis in human brain: Evidence for an age-dependent flux of 24s-hydroxycholesterol from the brain into the circulation. Proc. Natl. Acad. Sci. U.S.A., 1996, 93, 9799-9804. (Pubitemid 26296689)
26. Bjorkhem, I. Rediscovery of cerebrosterol. Lipids, 2007, 42, 5-14. (Pubitemid 46490739)
27. Lund, E.G.; Guileyardo, J.M.; Russell, D.W. Cdna cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brain. Proc. Natl. Acad. Sci. U.S.A., 1999, 96, 7238-7243. (Pubitemid 29299645)
28. Bjorkhem, I.; Lutjohann, D.; Diczfalusy, U.; Stahle, L.; Ahlborg, G.; Wahren, J. Cholesterol homeostasis in human brain: Turnover of 24s-hydroxycholesterol and evidence for a cerebral origin of most of this oxysterol in the circulation. J. Lipid Res., 1998, 39, 1594-1600. (Pubitemid 28377923)
29. Dietschy, J.M.; Turley, S.D. Thematic review series: Brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J. Lipid Res., 2004, 45, 1375-1397. (Pubitemid 39022664)
30. Kessel, A.; Ben-Tal, N.; May, S. Interactions of cholesterol with lipid bilayers: The preferred configuration and fluctuations. Biophys. J., 2001, 81, 643-658. (Pubitemid 32721440)
31. Pitas, R.E.; Boyles, J.K.; Lee, S.H.; Foss, D.; Mahley, R.W. Astrocytes synthesize apolipoprotein e and metabolize apolipoprotein e-containing lipoproteins. Biochim. Biophys. Acta., 1987, 917, 148-161. (Pubitemid 17231059)
32. Andersson, S.; Davis, D.L.; Dahlback, H.; Jornvall, H.; Russell, D.W. Cloning, structure, and expression of the mitochondrial cytochrome p-450 sterol 26-hydroxylase, a bile acid biosynthetic enzyme. J. Biol. Chem., 1989, 264, 8222-8229. (Pubitemid 19137311)
33. Reiss, A.B.; Martin, K.O.; Rojer, D.E.; Iyer, S.; Grossi, E.A.; Galloway, A.C.; Javitt, N.B. Sterol 27-hydroxylase: Expression in human arterial endothelium. J. Lipid Res., 1997, 38, 1254-1260. (Pubitemid 27281819)
34. Heverin, M.; Meaney, S.; Lutjohann, D.; Diczfalusy, U.; Wahren, J.; Bjorkhem, I. Crossing the barrier: Net flux of 27-hydroxycholesterol into the human brain. J. Lipid Res., 2005, 46, 1047-1052.
35. Heverin, M.; Bogdanovic, N.; Lutjohann, D.; Bayer, T.; Pikuleva, I.; Bretillon, L.; Diczfalusy, U.; Winblad, B.; Bjorkhem, I. Changes in the levels of cerebral and extracerebral sterols in the brain of patients with Alzheimer's disease. J. Lipid Res., 2004, 45, 186-193. (Pubitemid 38180529)
36. Bjorkhem, I.; Heverin, M.; Leoni, V.; Meaney, S.; Diczfalusy, U. Oxysterols and alzheimer's disease. Acta. Neurol. Scand. Suppl., 2006, 185, 43-49. (Pubitemid 44015224)
37. Silverman, R.B. The organic chemistry of enzyme-catalyzed reactions, Academic Press, 2002.
38. Mast, N.; White, M.A.; Bjorkhem, I.; Johnson, E.F.; Stout, C.D.; Pikuleva, I.A. Crystal structures of substrate-bound and substrate-free cytochrome p450 46a1, the principal cholesterol hydroxylase in the brain. Proc. Natl. Acad. Sci. U.S.A., 2008, 105, 9546-9551. (Pubitemid 352031338)
39. White, M.A.; Mast, N.; Bjorkhem, I.; Johnson, E.F.; Stout, C.D.; Pikuleva, I.A. Use of complementary cation and anion heavy-atom salt derivatives to solve the structure of cytochrome p450 46a1. Acta Crystallogr. D Biol. Crystallogr., 2008, 64, 487-495. (Pubitemid 351653934)
40. Nishimura, M.; Yaguti, H.; Yoshitsugu, H.; Naito, S.; Satoh, T. Tissue distribution of mrna expression of human cytochrome p450 isoforms assessed by high-sensitivity real-time reverse transcription pcr. Yakugaku Zasshi, 2003, 123, 369-375. (Pubitemid 41327466)
41. Mast, N.; Andersson, U.; Nakayama, K.; Bjorkhem, I.; Pikuleva, I.A. Expression of human cytochrome p450 46a1 in Escherichia coli: Effects of n-and c-terminal modifications. Arch. Biochem. Biophys., 2004, 428, 99-108. (Pubitemid 38844913)
42. McKhann, G.; Drachman, D.; Folstein, M.; Katzman, R.; Price, D.; Stadlan, E.M. Clinical diagnosis of alzheimer's disease: Report of the nincds-adrda work group under the auspices of department of health and human services task force on Alzheimer's disease. Neurology, 1984, 34, 939-944.
43. McKee, A.C.; Kosik, K.S.; Kowall, N.W. Neuritic pathology and dementia in alzheimer's disease. Ann. Neurol., 1991, 30, 156-165.
44. Querfurth, H.W; .LaFerla, F.M. Alzheimer's disease. N. Engl. J. Med., 2010, 362, 329-344.
45. Nelson, P.T.; Braak, H.; Markesbery, W.R. Neuropathology and cognitive impairment in alzheimer disease: A complex but coherent relationship. J. Neuropathol. Exp. Neurol, 2009, 68, 1-14.
46. De Strooper, B.; Annaert, W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J. Cell Sci., 2000, 113 (Pt 11), 1857-1870. (Pubitemid 30386490)
47. Brown, J., 3rd; Theisler, C.; Silberman, S.; Magnuson, D.; Gottardi-Littell, N.; Lee, J.M.; Yager, D.; Crowley, J.; Sambamurti, K.; Rahman, M.M.; Reiss, A.B.; Eckman, C.B.; Wolozin, B. Differential expression of cholesterol hydroxylases in alzheimer's disease. J. Biol. Chem., 2004, 279, 34674-34681. (Pubitemid 39318097)
48. Kim, W.S.; Chan, S.L.; Hill, A.F.; Guillemin, G.J.; Garner, B. Impact of 27-hydroxycholesterol on amyloid-beta peptide production and atp-binding cassette transporter expression in primary human neurons. J. Alzheimer's Dis., 2009, 16, 121-131.
49. Halford, R.W.; Russell, D.W. Reduction of cholesterol synthesis in the mouse brain does not affect amyloid formation in alzheimer's disease, but does extend lifespan. Proc. Natl. Acad. Sci. U.S.A., 2009, 106, 3502-3506.
50. Prasanthi, J.R.; Huls, A.; Thomasson, S.; Thompson, A.; Schommer, E.; Ghribi, O. Differential effects of 24-hydroxycholesterol and 27-hydroxycholesterol on beta-amyloid precursor protein levels and processing in human neuroblastoma sh-sy5y cells. Mol. Neurodegener., 2009, 4, 1.
51. Corder, E.H.; Saunders, A.M.; Strittmatter, W.J.; Schmechel, D.E.; Gaskell, P.C.; Small, G.W.; Roses, A.D.; Haines, J.L.; Pericak-Vance, M.A. Gene dose of apolipoprotein e type 4 allele and the risk of alzheimer's disease in late onset families. Science, 1993, 261, 921-923. (Pubitemid 23275809)
52. Bell, R.D.; Sagare, A.P.; Friedman, A.E.; Bedi, G.S.; Holtzman, D.M.; Deane, R.; Zlokovic, B.V. Transport pathways for clearance of human alzheimer's amyloid beta-peptide and apolipoproteins e and j in the mouse central nervous system. J. Cereb. Blood Flow Metab., 2007, 27, 909-918. (Pubitemid 46659038)
53. Helisalmi, S.; Vepsalainen, S.; Koivisto, A.M.; Mannermaa, A.; Iivonen, S.; Hiltunen, M.; Kiviniemi, V.; Soininen, H. Association of cyp46 intron 2 polymorphism in finnish alzheimer's disease samples and a global scale summary. J. Neurol. Neurosurg. Psychiatry, 2006, 77, 421-422.
54. Papassotiropoulos, A.; Streffer, J.R.; Tsolaki, M.; Schmid, S.; Thal, D.; Nicosia, F.; Iakovidou, V.; Maddalena, A.; Lutjohann, D.; Ghebremedhin, E.; Hegi, T.; Pasch, T.; Traxler, M.; Bruhl, A.; Benussi, L.; Binetti, G.; Braak, H.; Nitsch, R.M.; Hock, C. Increased brain beta-amyloid load, phosphorylated tau, and risk of alzheimer disease associated with an intronic cyp46 polymorphism. Arch. Neurol., 2003, 60, 29-35. (Pubitemid 36078105)
55. Fu, B.Y.; Ma, S.L.; Tang, N.L.; Tam, C.W.; Lui, V.W.; Chiu, H.F.; Lam, L.C. Cholesterol 24-hydroxylase (cyp46a1) polymorphisms are associated with faster cognitive deterioration in chinese older persons: A two-year follow up study. Int. J. Geriatr. Psychiatry, 2009, 24, 921-926.
56. Fernandez Del Pozo, V.; Alvarez Alvarez, M.; Fernandez Martinez, M.; Galdos Alcelay, L.; Gomez Busto, F.; Pena, J.A.; Alfonso-Sanchez, M.A.; Zarranz Imirizaldu, J.J.; de Pancorbo, M.M. Polymorphism in the cholesterol 24s-hydroxylase gene (cyp46a1) associated with the apoepsilon3 allele increases the risk of alzheimer's disease and of mild cognitive impairment progressing to alzheimer's disease. Dement. Geriatr Cogn. Disord., 2006, 21, 81-87. (Pubitemid 43107133)
57. Ma, S.L.; Tang, N.L.; Lam, L.C.; Chiu, H.F. Polymorphisms of the cholesterol 24-hydroxylase (cyp46a1) gene and the risk of alzheimer's disease in a chinese population. Int. Psychogeriatr, 2006, 18, 37-45.
58. Kolsch, H.; Lutjohann, D.; Jessen, F.; Popp, J.; Hentschel, F.; Kelemen, P.; Schmitz, S.; Maier, W.; Heun, R. Cyp46a1 variants influence alzheimer's disease risk and brain cholesterol metabolism. Eur Psychiatry, 2009, 24, 183-190.
59. Kabbara, A.; Payet, N.; Cottel, D.; Frigard, B.; Amouyel, P.; Lambert, J.C. Exclusion of cyp46 and apom as candidate genes for alzheimer's disease in a french population. Neurosci. Lett., 2004, 363, 139-143. (Pubitemid 38692606)
60. Ozturk, A.; Desai, P.P.; Minster, R.L.; Dekosky, S.T.; Kamboh, M.I. Three snps in the gsto1, gsto2 and prss11 genes on chromosome 10 are not associated with age-at-onset of Alzheimer's disease. Neurobiol. Aging., 2005, 26, 1161-1165. (Pubitemid 40726008)
61. Tedde, A.; Rotondi, M.; Cellini, E.; Bagnoli, S.; Muratore, L.; Nacmias, B.; Sorbi, S. Lack of association between the cyp46 gene polymorphism and italian late-onset sporadic alzheimer's disease. Neurobiol. Aging, 2006, 27, 773 e771-773 e773.
62. Ingelsson, M.; Jesneck, J.; Irizarry, M.C.; Hyman, B.T.; Rebeck, G.W. Lack of association of the cholesterol 24-hydroxylase (cyp46) intron 2 polymorphism with alzheimer's disease. Neurosci. Lett., 2004, 367, 228-231. (Pubitemid 39141233)
63. Kolsch, H.; Lutjohann, D.; Ludwig, M.; Schulte, A.; Ptok, U.; Jessen, F.; von Bergmann, K.; Rao, M.L.; Maier, W.; Heun, R. Polymorphism in the cholesterol 24s-hydroxylase gene is associated with alzheimer's disease. Mol. Psychiatry, 2002, 7, 899-902.
64. Leoni, V. Oxysterols as markers of neurological disease-a review. Scand. J. Clin. Lab. Invest., 2009, 69, 22-25.
65. Bretillon, L.; Siden, A.; Wahlund, L.O.; Lutjohann, D.; Minthon, L.; Crisby, M.; Hillert, J.; Groth, C.G.; Diczfalusy, U.; Bjorkhem, I. Plasma levels of 24s-hydroxycholesterol in patients with neurological diseases. Neurosci. Lett., 2000, 293, 87-90.
66. Kolsch, H.; Heun, R.; Kerksiek, A.; Bergmann, K. V.; Maier, W.; Lutjohann, D. Altered levels of plasma 24s-and 27-hydroxycholesterol in demented patients. Neurosci. Lett., 2004, 368, 303-308. (Pubitemid 39214973)
67. Solomon, A.; Leoni, V.; Kivipelto, M.; Besga, A.; Oksengard, A.R.; Julin, P.; Svensson, L.; Wahlund, L.O.; Andreasen, N.; Winblad, B.; Soininen, H.; Bjorkhem, I. Plasma levels of 24s-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with alzheimer's disease. Neurosci. Lett., 2009, 462, 89-93.
68. Papassotiropoulos, A.; Lutjohann, D.; Bagli, M.; Locatelli, S.; Jessen, F.; Rao, M.L.; Maier, W.; Bjorkhem, I.; von Bergmann, K.; Heun, R. Plasma 24s-hydroxycholesterol: A peripheral indicator of neuronal degeneration and potential state marker for Alzheimer's disease. Neuroreport., 2000, 11, 1959-1962.
69. van den Kommer, T.N.; Dik, M.G.; Comijs, H.C.; Fassbender, K.; Lutjohann, D.; Jonker, C. Total cholesterol and oxysterols: Early markers for cognitive decline in elderly? Neurobiol. Aging, 2009, 30, 534-545.
70. Papassotiropoulos, A.; Lutjohann, D.; Bagli, M.; Locatelli, S.; Jessen, F.; Buschfort, R.; Ptok, U.; Bjorkhem, I.; von Bergmann, K.; Heun, R. 24s-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J. Psychiatr. Res., 2002, 36, 27-32. (Pubitemid 34037845)
71. Schonknecht, P.; Lutjohann, D.; Pantel, J.; Bardenheuer, H.; Hartmann, T.; von Bergmann, K.; Beyreuther, K.; Schroder, J. Cerebrospinal fluid 24s-hydroxycholesterol is increased in patients with alzheimer's disease compared to healthy controls. Neurosci. Lett., 2002, 324, 83-85. (Pubitemid 34442684)
72. Hertze, J.; Minthon, L.; Zetterberg, H.; Vanmechelen, E.; Blennow, K.; Hansson, O. Evaluation of csf biomarkers as predictors of alzheimer's disease: A clinical follow-up study of 4.7 years. J. Alzheimers. Dis., 2010.
73. Teunissen, C.E.; Dijkstra, C.; Polman, C. Biological markers in csf and blood for axonal degeneration in multiple sclerosis. Lancet Neurol., 2005, 4, 32-41. (Pubitemid 40023234)
74. Barnett, M.H.; Prineas, J. W. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann. Neurol., 2004, 55, 458-468. (Pubitemid 38391962)
75. McFarland, H.F.; Martin, R. Multiple sclerosis: A complicated picture of autoimmunity. Nat Immunol, 2007, 8, 913-919. (Pubitemid 47300005)
76. Bjartmar, C.; Wujek, J.R.; Trapp, B.D. Axonal loss in the pathology of ms: Consequences for understanding the progressive phase of the disease. J Neurol Sci, 2003, 206, 165-171. (Pubitemid 36143722)
77. Podbielska, M.; Hogan, E.L. Molecular and immunogenic features of myelin lipids: Incitants or modulators of multiple sclerosis? Mult. Scler., 2009, 15, 1011-1029.
78. Kornek, B.; Storch, M.K.; Weissert, R.; Wallstroem, E.; Stefferl, A.; Olsson, T.; Linington, C.; Schmidbauer, M.; Lassmann, H. Multiple sclerosis and chronic autoimmune encephalomyelitis: A comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am. J. Pathol., 2000, 157, 267-276. (Pubitemid 30641742)
79. Bitsch, A.; Schuchardt, J.; Bunkowski, S.; Kuhlmann, T.; Bruck, W. Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation. Brain, 2000, 123 (Pt 6), 1174-1183. (Pubitemid 30312109)
80. Nave, K.A.; Trapp, B.D. Axon-glial signaling and the glial support of axon function. Annu. Rev. Neurosci., 2008, 31, 535-561.
81. Hisahara, S.; Okano, H.; Miura, M. Caspase-mediated oligodendrocyte cell death in the pathogenesis of autoimmune demyelination. Neurosci. Res., 2003, 46, 387-397. (Pubitemid 36842790)
82. Tegla, C.A.; Cudrici, C.; Rus, V.; Ito, T.; Vlaicu, S.; Singh, A.; Rus, H. Neuroprotective effects of the complement terminal pathway during demyelination: Implications for oligodendrocyte survival. J. Neuroimmunol., 2009, 213, 3-11.
83. Cudrici, C.; Niculescu, T.; Niculescu, F.; Shin, M.L.; Rus, H. Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes from apoptosis by complement. J. Rehabil. Res. Dev., 2006, 43, 123-132. (Pubitemid 43938753)
84. Henderson, A.P.; Barnett, M.H.; Parratt, J.D.; Prineas, J.W. Multiple sclerosis: Distribution of inflammatory cells in newly forming lesions. Ann. Neurol., 2009, 66, 739-753.
85. De Stefano, N.; Matthews, P.M.; Fu, L.; Narayanan, S.; Stanley, J.; Francis, G.S.; Antel, J. P.; Arnold, D.L. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain, 1998, 121 (Pt 8), 1469-1477. (Pubitemid 28349900)
86. Hein Nee Maier, K.; Kohler, A.; Diem, R.; Sattler, M.B.; Demmer, I.; Lange, P.; Bahr, M.; Otto, M. Biological markers for axonal degeneration in csf and blood of patients with the first event indicative for multiple sclerosis. Neurosci. Lett., 2008, 436, 72-76.
87. Schroepfer, G.J., Jr. Oxysterols: Modulators of cholesterol metabolism and other processes. Physiol. Rev., 2000, 80, 361-554. (Pubitemid 30060568)
88. Gilardi, F.; Viviani, B.; Galmozzi, A.; Boraso, M.; Bartesaghi, S.; Torri, A.; Caruso, D.; Crestani, M.; Marinovich, M.; de Fabiani, E. Expression of sterol 27-hydroxylase in glial cells and its regulation by liver x receptor signaling. Neurosci., 2009, 164, 530-540.
89. Bjorkhem, I. Are side-chain oxidized oxysterols regulators also in vivo? J. Lipid Res., 2009, 50 Suppl, S213-218.
90. Sacchetti, P.; Sousa, K.M.; Hall, A.C.; Liste, I.; Steffensen, K.R.; Theofilopoulos, S.; Parish, C.L.; Hazenberg, C.; Richter, L.A.; Hovatta, O.; Gustafsson, J.A.; Arenas, E. Liver x receptors and oxysterols promote ventral midbrain neurogenesis in vivo and in human embryonic stem cells. Cell Stem Cell, 2009, 5, 409-419.
91. Wang, L.; Schuster, G.U.; Hultenby, K.; Zhang, Q.; Andersson, S.; Gustafsson, J.A. Liver x receptors in the central nervous system: From lipid homeostasis to neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A., 2002, 99, 13878-13883. (Pubitemid 35215474)
92. Quintana, F.J.; Farez, M.F.; Viglietta, V.; Iglesias, A.H.; Merbl, Y.; Izquierdo, G.; Lucas, M.; Basso, A.S.; Khoury, S.J.; Lucchinetti, C.F.; Cohen, I.R.; Weiner, H.L. Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc. Natl. Acad. Sci. U.S.A., 2008, 105, 18889-18894.
93. Teunissen, C.E.; Floris, S.; Sonke, M.; Dijkstra, C.D.; De Vries, H.E.; Lutjohann, D. 24s-hydroxycholesterol in relation to disease manifestations of acute experimental autoimmune encephalomyelitis. J. Neurosci. Res., 2007, 85, 1499-1505. (Pubitemid 46724393)
94. Karrenbauer, V.D.; Leoni, V.; Lim, E.T.; Giovannoni, G.; Ingle, G.T.; Sastre-Garriga, J.; Thompson, A.J.; Rashid, W.; Davies, G.; Miller, D.H.; Bjorkhem, I.; Masterman, T. Plasma cerebrosterol and magnetic resonance imaging measures in multiple sclerosis. Clin. Neurol Neurosurg., 2006, 108, 456-460. (Pubitemid 43744509)
95. Teunissen, C.E.; Dijkstra, C.D.; Polman, C.H.; Hoogervorst, E.L.; von Bergmann, K.; Lutjohann, D. Decreased levels of the brain specific 24s-hydroxycholesterol and cholesterol precursors in serum of multiple sclerosis patients. Neurosci. Lett., 2003, 347, 159-162. (Pubitemid 37271941)
96. Leoni, V.; Masterman, T.; Mousavi, F.S.; Wretlind, B.; Wahlund, L.O.; Diczfalusy, U.; Hillert, J.; Bjorkhem, I. Diagnostic use of cerebral and extracerebral oxysterols. Clin. Chem. Lab. Med., 2004, 42, 186-191. (Pubitemid 38401447)
97. Bjorkhem, I. Crossing the barrier: Oxysterols as cholesterol transporters and metabolic modulators in the brain. J. Intern. Med., 2006, 260, 493-508. (Pubitemid 44772369)
98. Ong, W.Y.; Kim, J.H.; He, X.; Chen, P.; Farooqui, A.A.; Jenner, A.M. Changes in brain cholesterol metabolome after excitotoxicity. Mol. Neurobiol., 2010, 41, 299-313.
99. He, X.; Jenner, A.M.; Ong, W.Y.; Farooqui, A.A.; Patel, S.C. Lovastatin modulates increased cholesterol and oxysterol levels and has a neuroprotective effect on rat hippocampal neurons after kainate injury. J. Neuropathol. Exp. Neurol, 2006, 65, 652-663. (Pubitemid 44297256)
100. Diestel, A.; Aktas, O.; Hackel, D.; Hake, I.; Meier, S.; Raine, C.S.; Nitsch, R.; Zipp, F.; Ullrich, O. Activation of microglial poly(adp-ribose)- polymerase-1 by cholesterol breakdown products during neuroinflammation: A link between demyelination and neuronal damage. J. Exp. Med., 2003, 198, 1729-1740. (Pubitemid 37494165)
101. Leoni, V.; Lutjohann, D.; Masterman, T. Levels of 7-oxocholesterol in cerebrospinal fluid are more than one thousand times lower than reported in multiple sclerosis. J. Lipid Res., 2005, 46, 191-195. (Pubitemid 40271081)
102. Palozza, P.; Simone, R.; Catalano, A.; Boninsegna, A.; Bohm, V.; Frohlich, K.; Mele, M.C.; Monego, G.; Ranelletti, F.O. Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. J. Nutr. Biochem., 2010, 21, 34-46.
103. Vejux, A.; Malvitte, L.; Lizard, G. Side effects of oxysterols: Cytotoxicity, oxidation, inflammation, and phospholipidosis. Braz. J. Med. Biol. Res., 2008, 41, 545-556.
104. Vejux, A.; Lizard, G. Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol. Aspects. Med., 2009, 30, 153-170.
105. Lemaire-Ewing, S.; Prunet, C.; Montange, T.; Vejux, A.; Berthier, A.; Bessede, G.; Corcos, L.; Gambert, P.; Neel, D.; Lizard, G. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell. Biol. Toxicol., 2005, 21, 97-114. (Pubitemid 41253203)
106. Trousson, A.; Bernard, S.; Petit, P.X.; Liere, P.; Pianos, A.; El Hadri, K.; Lobaccaro, J.M.; Ghandour, M.S.; Raymondjean, M.; Schumacher, M.; Massaad, C. 25-hydroxycholesterol provokes oligodendrocyte cell line apoptosis and stimulates the secreted phospholipase a2 type iia via lxr beta and pxr. J. Neurochem., 2009, 109, 945-958.
107. Fink, J.K. The hereditary spastic paraplegias: Nine genes and counting. Arch. Neurol, 2003, 60, 1045-1049. (Pubitemid 36975789)
108. Depienne, C.; Stevanin, G.; Brice, A.; Durr, A. Hereditary spastic paraplegias: An update Curr. Opin. Neurol., 2007, 20, 674-680. (Pubitemid 350085009)
109. Behan, W.M.; Maia, M. Strumpell's familial spastic paraplegia: Genetics and neuropathology. J. Neurol. Neurosurg. Psychiatry, 1974, 37, 8-20.
110. Schwarz, G.A.; Liu, C.N. Hereditary (familial) spastic paraplegia; further clinical and pathologic observations. AMA Arch. Neurol. Psychiatry, 1956, 75, 144-162.
111. Harding, A.E. Hereditary spastic paraplegias. Semin. Neurol., 1993, 13, 333-336. (Pubitemid 24017067)
112. Schule, R.; Brandt, E.; Karle, K.N.; Tsaousidou, M.; Klebe, S.; Klimpe, S.; Auer-Grumbach, M.; Crosby, A.H.; Hubner, C.A.; Schols, L.; Deufel, T.; Beetz, C. Analysis of cyp7b1 in non-consanguineous cases of hereditary spastic paraplegia. Neurogenetics, 2009, 10, 97-104.
113. Tsaousidou, M.K.; Ouahchi, K.; Warner, T.T.; Yang, Y.; Simpson, M.A.; Laing, N.G.; Wilkinson, P.A.; Madrid, R.E.; Patel, H.; Hentati, F.; Patton, M.A.; Hentati, A.; Lamont, P.J.; Siddique, T.; Crosby, A.H. Sequence alterations within cyp7b1 implicate defective cholesterol homeostasis in motor-neuron degeneration. Am. J. Hum. Genet., 2008, 82, 510-515.
114. Biancheri, R.; Ciccolella, M.; Rossi, A.; Tessa, A.; Cassandrini, D.; Minetti, C.; Santorelli, F.M. White matter lesions in spastic paraplegia with mutations in spg5/cyp7b1. Neuromuscul. Disord., 2009, 19, 62-65.
115. Goizet, C.; Boukhris, A.; Durr, A.; Beetz, C.; Truchetto, J.; Tesson, C.; Tsaousidou, M.; Forlani, S.; Guyant-Marechal, L.; Fontaine, B.; Guimaraes, J.; Isidor, B.; Chazouilleres, O.; Wendum, D.; Grid, D.; Chevy, F.; Chinnery, P.F.; Coutinho, P.; Azulay, J.P.; Feki, I.; Mochel, F.; Wolf, C.; Mhiri, C.; Crosby, A.; Brice, A.; Stevanin, G. Cyp7b1 mutations in pure and complex forms of hereditary spastic paraplegia type 5. Brain, 2009, 132, 1589-1600.
116. Beaulieu, M.; Ropert-Coudert, Y.; Le Maho, Y.; Ancel, A.; Criscuolo, F. Foraging in an oxidative environment: Relationship between delta13c values and oxidative status in adelie penguins. Proc. Biol. Sci., 2010, 277, 1087-1092.
117. Wu, Z.; Martin, K.O.; Javitt, N.B.; Chiang, J.Y. Structure and functions of human oxysterol 7alpha-hydroxylase cdnas and gene cyp7b1. J. Lipid Res., 1999, 40, 2195-2203. (Pubitemid 30017521)
118. Stiles, A.R.; McDonald, J.G.; Bauman, D.R.; Russell, D.W. Cyp7b1: One cytochrome p450, two human genetic diseases, and multiple physiological functions. J. Biol. Chem., 2009, 284, 28485-28489.
119. Martin, K.O.; Reiss, A.B.; Lathe, R.; Javitt, N.B. 7 alpha-hydroxylation of 27-hydroxycholesterol: Biologic role in the regulation of cholesterol synthesis. J. Lipid Res., 1997, 38, 1053-1058. (Pubitemid 27255213)
120. Danielsson, H.; Einarsson, K.; Johansson, G. Effect of biliary drainage on individual reactions in the conversion of cholesterol to taurochlic acid. Bile acids and steroids 180. Eur. J. Biochem., 1967, 2, 44-49.
121. Russell, D.W. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem., 2003, 72, 137-174. (Pubitemid 36930444)
122. Schule, R.; Siddique, T.; Deng, H.X.; Yang, Y.; Donkervoort, S.; Hansson, M.; Madrid, R.E.; Siddique, N.; Schols, L.; Bjorkhem, I. Marked accumulation of 27-hydroxycholesterol in spg5 patients with hereditary spastic paresis. J. Lipid Res., 2010, 51, 819-823.
123. Ueki, I.; Kimura, A.; Chen, H.L.; Yorifuji, T.; Mori, J.; Itoh, S.; Maruyama, K.; Ishige, T.; Takei, H.; Nittono, H.; Kurosawa, T.; Kage, M.; Matsuishi, T. Srd5b1 gene analysis needed for the accurate diagnosis of primary 3-oxodelta4-steroid 5beta-reductase deficiency. J. Gastroenterol. Hepatol., 2009, 24, 776-785.
124. Setchell, K.D.; Schwarz, M.; O'Connell, N.C.; Lund, E.G.; Davis, D.L.; Lathe, R.; Thompson, H.R.; Weslie Tyson, R.; Sokol, R.J.; Russell, D.W. Identification of a new inborn error in bile acid synthesis: Mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. J. Clin. Invest., 1998, 102, 1690-1703. (Pubitemid 28516254)
125. Ueki, I.; Kimura, A.; Nishiyori, A.; Chen, H.L.; Takei, H.; Nittono, H.; Kurosawa, T. Neonatal cholestatic liver disease in an asian patient with a homozygous mutation in the oxysterol 7alpha-hydroxylase gene. J. Pediatr. Gastroenterol. Nutr., 2008, 46, 465-469. (Pubitemid 351457885)
126. Erichsen, A.K.; Koht, J.; Stray-Pedersen, A.; Abdelnoor, M.; Tallaksen, C.M. Prevalence of hereditary ataxia and spastic paraplegia in southeast norway: A population-based study. Brain, 2009, 132, 1577-1588.
127. Diczfalusy, U.; Olofsson, K.E.; Carlsson, A.M.; Gong, M.; Golenbock, D.T.; Rooyackers, O.; Flaring, U.; Bjorkbacka, H. Marked upregulation of cholesterol 25-hydroxylase expression by lipopolysaccharide. J. Lipid Res., 2009, 50, 2258-2264.
128. Bauman, D.R.; Bitmansour, A.D.; McDonald, J.G.; Thompson, B.M.; Liang, G.; Russell, D.W. 25-hydroxycholesterol secreted by macrophages in response to toll-like receptor activation suppresses immunoglobulin a production. Proc. Natl Acad. Sci. U.S.A., 2009, 106, 16764-16769.
129. Clayton, P.T.; Verrips, A.; Sistermans, E.; Mann, A.; Mieli-Vergani, G.; Wevers, R. Mutations in the sterol 27-hydroxylase gene (cyp27a) cause hepatitis of infancy as well as cerebrotendinous xanthomatosis. J. Inherit. Metab. Dis., 2002, 25, 501-513. (Pubitemid 36104385)
130. Bjorkhem, I.; Boberg, K.M.; Leitersdorf, E. The metabolic and molecular basis of inherited disease, McGraw-Hill Book Co., New York, 2001.
131. Chang, J. Y.; Chavis, J.A.; Liu, L.Z.; Drew, P.D. Cholesterol oxides induce programmed cell death in microglial cells. Biochem. Biophys. Res. Commun., 1998, 249, 817-821. (Pubitemid 28441921)
132. Chang, J.Y; .Liu, L.Z. Neurotoxicity of cholesterol oxides on cultured cerebellar granule cells. Neurochem. Int., 1998, 32, 317-323. (Pubitemid 28174983)
133. Chang, J.Y.; Liu, L.Z. Toxicity of cholesterol oxides on cultured neuroretinal cells. Curr. Eye Res., 1998, 17, 95-103. (Pubitemid 28039674)
134. Chang, J.Y.; Phelan, K.D.; Chavis, J.A. Neurotoxicity of 25-oh-cholesterol on sympathetic neurons. Brain Res. Bull., 1998, 45, 615-622. (Pubitemid 28259033)
135. Chang, J.Y.; Phelan, K.D.; Liu, L.Z. Neurotoxicity of 25-oh-cholesterol on ngf-differentiated pc12 cells. Neurochem. Res., 1998, 23, 7-16. (Pubitemid 28145685)
136. Riendeau, V.; Garenc, C. Effect of 27-hydroxycholesterol on survival and death of human macrophages and vascular smooth muscle cells. J. Alzheimers Dis., In press.
137. Leoni, V.; Masterman, T.; Patel, P.; Meaney, S.; Diczfalusy, U.; Bjorkhem, I. Side chain oxidized oxysterols in cerebrospinal fluid and the integrity of blood-brain and blood-cerebrospinal fluid barriers. J. Lipid Res., 2003, 44, 793-799. (Pubitemid 37279681)
138. Pandak, W.M.; Ren, S.; Marques, D.; Hall, E.; Redford, K.; Mallonee, D.; Bohdan, P.; Heuman, D.; Gil, G.; Hylemon, P. Transport of cholesterol into mitochondria is rate-limiting for bile acid synthesis via the alternative pathway in primary rat hepatocytes. J. Biol. Chem., 2002, 277, 48158-48164. (Pubitemid 35470765)
139. Rose, K.A.; Stapleton, G.; Dott, K.; Kieny, M.P.; Best, R.; Schwarz, M.; Russell, D.W.; Bjorkhem, I.; Seckl, J.; Lathe, R. Cyp7b, a novel brain cytochrome p450, catalyzes the synthesis of neurosteroids 7alpha-hydroxy dehydroepiandrosterone and 7alpha-hydroxy pregnenolone. Proc. Natl. Acad. Sci. U.S.A., 1997, 94, 4925-4930. (Pubitemid 27214712)
140. Charalampopoulos, I.; Remboutsika, E.; Margioris, A.N.; Gravanis, A. Neurosteroids as modulators of neurogenesis and neuronal survival. Trends Endocrinol. Metab., 2008, 19, 300-307.
141. Wojtal, K.; Trojnar, M.K.; Czuczwar, S.J. Endogenous neuroprotective factors: Neurosteroids. Pharmacol. Rep., 2006, 58, 335-340. (Pubitemid 44111068)
142. Sirover, M.A. New nuclear functions of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in mammalian cells. J. Cell Biochem., 2005, 95, 45-52. (Pubitemid 41420214)
143. Schwarz, M.; Lund, E.G.; Lathe, R.; Bjorkhem, I.; Russell, D.W. Identification and characterization of a mouse oxysterol 7alpha-hydroxylase cdna. J. Biol. Chem., 1997, 272, 23995-24001. (Pubitemid 27410983)
144. Li-Hawkins, J.; Lund, E.G.; Turley, S.D.; Russell, D.W. Disruption of the oxysterol 7alpha-hydroxylase gene in mice. J. Biol. Chem., 2000, 275, 16536-16542. (Pubitemid 30398877)
145. Meir, K.; Kitsberg, D.; Alkalay, I.; Szafer, F.; Rosen, H.; Shpitzen, S.; Avi, L.B.; Staels, B.; Fievet, C.; Meiner, V.; Bjorkhem, I.; Leitersdorf, E. Human sterol 27-hydroxylase (cyp27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. J. Biol. Chem., 2002, 277, 34036-34041.
146. Golanska, E.; Hulas-Bigoszewska, K.; Sieruta, M.; Zawlik, I.; Witusik, M.; Gresner, S.M.; Sobow, T.; Styczynska, M.; Peplonska, B.; Barcikowska, M.; Liberski, P. P.; Corder, E.H. Earlier onset of alzheimer's disease: Risk polymorphisms within prnp, prnd, cyp46, and apoe genes. J. Alzheimers Dis., 2009, 17, 359-368.